Clene, Inc. (Nasdaq: CLNN) and its subsidiary, Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment ...
Under current regulations, spouses can receive benefits only if the veteran lived with the disability for at least eight years before dying.
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...
The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic ...
Results demonstrated statistically significant effects on biomarkers that predict ALS disease progression and severity Evidence of brain pe ...
2h
Zacks Investment Research on MSNIonis Out-Licenses Rights for Rare Blood Cancer Drug to OnoIonis Pharmaceuticals IONS signed a license agreement with Japan-based Ono Pharmaceutical. Per the terms, Ono has acquired ...
AKGsOVIHAMS, a leading healthcare institution, has marked progress in treating ALS using integrative medicine. Known for combining conventional and alternative therapies, the institute has shown ...
Startup Cognixion, which has developed a noninvasive brain-computer interface, has begun a clinical trial for patients with ...
Singer Roberta Flack dies, 88. Harlem's Abyssinian Church memorializes her March 10th with a public 'Celebration of Life.' ...
Despite being diagnosed with Amyotrophic Lateral Sclerosis, or ALS, a longtime coach at Northern Bedford County High School ...
A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and phosphorylated tau 181.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results